Patent: 10,369,219
✉ Email this page to a colleague
Summary for Patent: 10,369,219
| Title: | Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition |
| Abstract: | The present invention aims to provide a composition for promoting humoral immunity induction and a vaccine pharmaceutical composition that can be universally used for various antigens in inducing humoral immunity to antigens, contain a Th2 reaction promoter, and exerts a high humoral immunity inducing effect. The present invention relates to a vaccine pharmaceutical composition containing an antigen for humoral immunity induction and at least one Th2 reaction promoter. |
| Inventor(s): | Shishido; Takuya (Osaka, JP), Asari; Daisuke (Osaka, JP), Matsushita; Kyohei (Osaka, JP), Hori; Mitsuhiko (Osaka, JP) |
| Assignee: | NITTO DENKO CORPORATION (Osaka, JP) |
| Application Number: | 15/501,271 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,369,219
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Jubilant Hollisterstier Llc | N/A | positive skin test control-histamine | Injection | 103891 | March 13, 1924 | 10,369,219 | 2035-08-04 |
| Seqirus Inc. | AGRIFLU | influenza virus vaccine | Injection | 125297 | November 27, 2009 | 10,369,219 | 2035-08-04 |
| Glaxosmithkline Biologicals | AREXVY | respiratory syncytial virus vaccine, adjuvanted | For Injection | 125775 | May 03, 2023 | 10,369,219 | 2035-08-04 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,369,219
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 106573048 | ⤷ Start Trial |
| European Patent Office | 3178491 | ⤷ Start Trial |
| Japan | 2016034941 | ⤷ Start Trial |
| Japan | 6893075 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
